This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "C-CDA R2.1 Comment Submission"

From HL7Wiki
Jump to navigation Jump to search
Line 14: Line 14:
 
==Comments==
 
==Comments==
 
''Enter your comments below this line.''
 
''Enter your comments below this line.''
 +
  
  
 
{| class="wikitable sortable" style="font-size:90%; width:99%;"
 
{| class="wikitable sortable" style="font-size:90%; width:99%;"
 
|-
 
|-
−
! style="font-size:110%; width:5px; background: #B0C4DE" | Item
+
! style="font-size:110%; background: #B0C4DE" | Item
−
! style="font-size:110%; width:150px; background: #B0C4DE" | Summary
+
! style="font-size:110%; width:140px; background: #B0C4DE" | Name
−
! style="font-size:110%; width:10px; background: #B0C4DE" | DSTU Comment #
+
! style="font-size:110%; width:160px; background: #B0C4DE" | e-mail
−
! style="font-size:110%; width:50px; background: #B0C4DE" | Link to full DSTU Comment
+
! style="font-size:110%; background: #B0C4DE" | Summary of Issue
 +
! style="font-size:110%; background: #B0C4DE" | Existing Wording
 +
! style="font-size:110%; background: #B0C4DE" | Proposed Wording
 +
! style="font-size:110%; background: #B0C4DE" | Comments
  
 
|-
 
|-
 
|1
 
|1
−
|Incorporation of new code for use in the Colon TNM Category 2.16.840.1.113883.10.20.30.3.54 template. And, refine the National Cancer Institute (NCI) Common Toxicity Criteria Adverse Event (CTCAE) value set (2.16.840.1.113883.11.20.11.35) to include new codes and clarify the set of concepts to be included.  Change the name of the value set to align with the refined purpose. New value set name is "Neuropathy at end of treament grade" to align with the Colon Cancer Adjuvant Treatment Plan and Summary form.
+
|Example Person
−
|600
+
|example.person@mymail.net
−
|[http://www.hl7.org/dstucomments/showdetail.cfm?dstuid=135 comment link]
+
|Short problem statement
 +
|This text is how the issue is currently documented in the IG
 +
|This text is the proposal for how the issue could be documented differently in the IG
 +
|This is why the issue is important or tells why the proposed wording is beneficial
 
|}
 
|}

Revision as of 16:55, 26 June 2015

SDWG completed an update to Consolidated CDA R2.0 to enable a C-CDA 2.1 instance to be created that can be used without requiring change to the product supporting C-CDA 1.1. A full description of the project is available on Project Insight Consolidated CDA DSTU 2013 Update (1014). This update is available to HL7 members INSERT_LINK_C-CDAR2.1 for review prior to reconciliation and publication. As a minor DSTU update, this new version will not go through the usual HL7 balloting process but will use the DSTU Update process with industry review on the HL7 wiki.

Before submitting comments, please review the C-CDA R2.1 Approved Compatibility Principles

Changes open for comment:

  1. Volume 1 edits
  2. Volume 2 edits to prose, figures, and specific conformance statements

Edits available for comment are identified by....

During the comment period 7/1/2015 - 7/13/2015, please submit your comments on this wiki page including at least your name, item, existing wording, proposed wording, and comment. Thank you.

Comments

Enter your comments below this line.


Item Name e-mail Summary of Issue Existing Wording Proposed Wording Comments
1 Example Person example.person@mymail.net Short problem statement This text is how the issue is currently documented in the IG This text is the proposal for how the issue could be documented differently in the IG This is why the issue is important or tells why the proposed wording is beneficial
Retrieved from "https://wiki.hl7.org/w/index.php?title=C-CDA_R2.1_Comment_Submission&oldid=101627"